Identification of Chemo and Radio-Resistant Sub-Population of Stem Cells in Human Cervical Cancer HeLa Cells

References

• Vu M, Yu J, Awolude OA, Chuang L. Cervical cancer worldwide. Curr Probl Cancer. 2018;42(5):457–465. doi:10.1016/j.currproblcancer.2018.06.003.
   PubMed Web of Science ®Google Scholar
• Garg M, Kanojia D, Salhan S, Suri S, Gupta A, Lohiya NK, et al. Sperm-associated antigen 9 is a biomarker for early cervical carcinoma. Cancer. 2009;115(12):2671–2683. doi:10.1002/cncr.24293.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Hirte HW, Strychowsky JE, Oliver T, Fung-Kee-Fung M, Elit L, Oza AM. Chemotherapy for recurrent, metastatic, or persistent cervical cancer: a systematic review. Int J Gynecol Cancer. 2007;17(6):1194–1204. doi:10.1111/j.1525-1438.2007.00900.x.
   PubMed Web of Science ®Google Scholar
• Pergialiotis V, Bellos I, Thomakos N, Haidopoulos D, Perrea DN, Kontzoglou K, et al. Survival outcomes of patients with cervical cancer and accompanying hydronephrosis: a systematic review of the literature. Oncol Rev. 2019;13(1):387. doi:10.4081/oncol.2019.387.
   PubMed Web of Science ®Google Scholar
• Dreyer G, Snyman LC, Mouton A, Lindeque BG. Management of recurrent cervical cancer. Best Pract Res Clin Obstet Gynaecol. 2005;19(4):631–644. doi:10.1016/j.bpobgyn.2005.03.003.
   PubMed Web of Science ®Google Scholar
• Martens JE, Arends J, Van der Linden PJ, De Boer BA, Helmerhorst TJ. Cytokeratin 17 and p63 are markers of the HPV target cell, the cervical stem cell. Anticancer Res. 2004;24(2B):771–775.
   PubMed Web of Science ®Google Scholar
• Hulman G, Pickles CJ, Gie CA, Dowling FM, Stocks PJ, Dixon R. Frequency of cervical intraepithelial neoplasia following large loop excision of the transformation zone. J Clin Pathol. 1998;51(5):375–377. doi:10.1136/jcp.51.5.375.
   PubMed Web of Science ®Google Scholar
• De Lorenzo BH, Ramos MC, Michelin MA, Murta EF. Progress in the use of immunotherapy to treat uterine cervical cancer. Tumori. 2009;95(1):1–7.
   PubMed Web of Science ®Google Scholar
• Golub TR. Genome-wide views of cancer. N Engl J Med. 2001;344(8):601–602. doi:10.1056/NEJM200102223440809.
   PubMed Web of Science ®Google Scholar
• Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer. 2003;3(12):895–902. doi:10.1038/nrc1232.
   PubMed Web of Science ®Google Scholar
• Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414(6859):105–111. doi:10.1038/35102167.
   PubMed Web of Science ®Google Scholar
• Tieche CC, Gao Y, Buhrer ED, Hobi N, Berezowska SA, Wyler K, et al. Tumor initiation capacity and therapy resistance are differential features of EMT-related subpopulations in the NSCLC cell line A549. Neoplasia. 2019;21(2):185–196. doi:10.1016/j.neo.2018.09.008.
   PubMed Web of Science ®Google Scholar
• Abbott A. Cancer: the root of the problem. Nature. 2006;442(7104):742–743. doi:10.1038/442742a.
   PubMed Web of Science ®Google Scholar
• Sun Y, Yoshida T, Okabe M, Zhou K, Wang F, Soko C, et al. Isolation of stem-like cancer cells in primary endometrial cancer using cell surface markers CD133 and CXCR4. Transl Oncol. 2017;10(6):976–987. doi:10.1016/j.tranon.2017.07.007.
   PubMed Web of Science ®Google Scholar
• Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer. 2008;8(10):755–768. doi:10.1038/nrc2499.
   PubMed Web of Science ®Google Scholar
• Cabanillas R, Llorente JL. The stem cell network model: clinical implications in cancer. Eur Arch Otorhinolaryngol. 2009;266(2):161–170. doi:10.1007/s00405-008-0809-3.
   PubMed Web of Science ®Google Scholar
• Eyler CE, Rich JN. Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. J Clin Oncol. 2008;26(17):2839–2845. doi:10.1200/JCO.2007.15.1829.
   PubMed Web of Science ®Google Scholar
• Toledo-Guzman ME, Bigoni-Ordonez GD, Ibanez Hernandez M. Ortiz-Sanchez E. Cancer stem cell impact on clinical oncology. World J Stem Cells. 2018;10(12):183–195. doi:10.4252/wjsc.v10.i12.183.
   PubMed Web of Science ®Google Scholar
• Massard C, Deutsch E, Soria JC. Tumour stem cell-targeted treatment: elimination or differentiation. Ann Oncol. 2006;17(11):1620–1624. doi:10.1093/annonc/mdl074.
   PubMed Web of Science ®Google Scholar
• Huang P, Wang CY, Gou SM, Wu HS, Liu T, Xiong JX. Isolation and biological analysis of tumor stem cells from pancreatic adenocarcinoma. WJG. 2008;14(24):3903–3907. doi:10.3748/wjg.14.3903.
   PubMed Web of Science ®Google Scholar
• Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003;100(7):3983–3988. doi:10.1073/pnas.0530291100.
   PubMed Web of Science ®Google Scholar
• Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res. 2008;68(11):4311–4320. doi:10.1158/0008-5472.CAN-08-0364.
   PubMed Web of Science ®Google Scholar
• Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004;64(19):7011–7021. doi:10.1158/0008-5472.CAN-04-1364.
   PubMed Web of Science ®Google Scholar
• Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005;65(23):10946–10951. doi:10.1158/0008-5472.CAN-05-2018.
   PubMed Web of Science ®Google Scholar
• Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. PNAS. 2007;104(3):973–978. doi:10.1073/pnas.0610117104.
   PubMed Web of Science ®Google Scholar
• Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell. 2005;121(6):823–835. doi:10.1016/j.cell.2005.03.032.
   PubMed Web of Science ®Google Scholar
• Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, et al. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell. 2008;13(2):153–166. doi:10.1016/j.ccr.2008.01.013.
   PubMed Web of Science ®Google Scholar
• Cho RW, Wang X, Diehn M, Shedden K, Chen GY, Sherlock G, et al. Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors. Stem Cells. 2008;26(2):364–371. doi:10.1634/stemcells.2007-0440.
   PubMed Web of Science ®Google Scholar
• Ouhtit A, Abd Elmageed ZY, Abdraboh ME, Lioe TF, Raj MH. In vivo evidence for the role of CD44s in promoting breast cancer metastasis to the liver. Am J Pathol. 2007;171(6):2033–2039. doi:10.2353/ajpath.2007.070535.
   PubMed Web of Science ®Google Scholar
• Vassilopoulos A, Wang RH, Petrovas C, Ambrozak D, Koup R, Deng CX. Identification and characterization of cancer initiating cells from BRCA1 related mammary tumors using markers for normal mammary stem cells. Int J Biol Sci. 2008;4(3):133–142. doi:10.7150/ijbs.4.133.
   PubMed Web of Science ®Google Scholar
• Editorial. HeLa cell sequela. G3 Genes Gemoes Genetics. 2013;3(6):927. doi:10.1534/g3.113.006304.
   Web of Science ®Google Scholar
• Feng D, Peng C, Li C, Zhou Y, Li M, Ling B, et al. Identification and characterization of cancer stem-like cells from primary carcinoma of the cervix uteri. Oncol Rep. 2009;22(5):1129–1134. doi:10.3892/or_00000545.
   PubMed Web of Science ®Google Scholar
• Ji J, Zheng PS. Expression of Sox2 in human cervical carcinogenesis. Hum Pathol. 2010;41(10):1438–1447. doi:10.1016/j.humpath.2009.11.021.
   PubMed Web of Science ®Google Scholar
• Lopez J, Poitevin A, Mendoza-Martinez V, Perez-Plasencia C, Garcia-Carranca A. Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance. BMC Cancer. 2012;12(1):48. doi:10.1186/1471-2407-12-48.
   PubMedGoogle Scholar
• Johnson S, Nguyen V, Coder D. Assessment of cell viability. Curr Protoc Cytom. 2013;Suppl.64,Unit 9.2:1–26. doi:10.1002/0471142956.cy0902s64.
   PubMedGoogle Scholar
• Zhang C, Li C, He F, Cai Y, Yang H. Identification of CD44 + CD24+ gastric cancer stem cells. J Cancer Res Clin Oncol. 2011;137(11):1679–1686. doi:10.1007/s00432-011-1038-5.
   PubMed Web of Science ®Google Scholar
• Hsu KH, Tsai HW, Shan YS, Lin PW. Significance of CD44 expression in gastrointestinal stromal tumors in relation to disease progression and survival. World J Surg. 2007;31(7):1438–44. doi:10.1007/s00268-007-9088-1.
   PubMed Web of Science ®Google Scholar
• Senbanjo LT, Chellaiah M. CD44: a multifunctional cell surface adhesion receptor is a regulator of progression and metastasis of cancer cells. Biology D. 2017;5:18.
   Web of Science ®Google Scholar
• Ayre DC, Christian SL. CD24: A Rheostat That Modulates Cell Surface Receptor Signaling of Diverse Receptors. Front Cell Dev Biol. 2016;4:146. doi:10.3389/fcell.2016.00146.
   PubMed Web of Science ®Google Scholar
• Olsson E, Honeth G, Bendahl PO, Saal LH, Gruvberger-Saal S, Ringner M, et al. CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers. BMC Cancer. 2011;11:418. doi:10.1186/1471-2407-11-418.
   PubMed Web of Science ®Google Scholar
• Su J, Xu XH, Huang Q, Lu MQ, Li DJ, Xue F, et al. Identification of cancer stem-like CD44+ cells in human nasopharyngeal carcinoma cell line. Arch Med Res. 2011;42(1):15–21. doi:10.1016/j.arcmed.2011.01.007.
   PubMed Web of Science ®Google Scholar
• Gokul G, Ramakrishna G, Khosla S. Reprogramming of HeLa cells upon DNMT3L overexpression mimics carcinogenesis. Epigenetics. 2009;4(5):322–9. doi:10.4161/epi.4.5.9239.
   PubMed Web of Science ®Google Scholar